Literature DB >> 30617304

RACK1 regulates centriole duplication by controlling localization of BRCA1 to the centrosome in mammary tissue-derived cells.

Yuki Yoshino1, Huicheng Qi1, Ryo Kanazawa1, Mami Sugamata1, Kenta Suzuki1, Akihiro Kobayashi1, Kazuha Shindo1, Ayako Matsuzawa2, Shun Shibata2, Shino Endo1, Yutaro Miyanishi1, Tatsuro Shimaoka3, Chikashi Ishioka4, Shin-Ichiro Kanno5, Akira Yasui5, Natsuko Chiba6.   

Abstract

Breast cancer gene 1 (BRCA1) is a tumor suppressor that is associated with hereditary breast and ovarian cancer. BRCA1 functions in DNA repair and centrosome regulation together with BRCA1-associated RING domain protein (BARD1), a heterodimer partner of BRCA1. Obg-like ATPase 1 (OLA1) was identified as a protein that interacts with BARD1. OLA1 regulates the centrosome by binding to and collaborating with BRCA1 and BARD1. We identified receptor for activated C kinase (RACK1) as a protein that interacts with OLA1. RACK1 directly bound to OLA1, the N-terminal region of BRCA1, and γ-tubulin, associated with BARD1, and localized the centrosomes throughout the cell cycle. Knockdown of RACK1 caused abnormal centrosomal localization of BRCA1 and abrogated centriole duplication. Overexpression of RACK1 increased the centrosomal localization of BRCA1 and caused centrosome amplification due to centriole overduplication. The number of centrioles in cells with two γ-tubulin spots was higher in cell lines derived from mammary tissue compared to those derived from other tissues. The effects of aberrant RACK1 expression level on centriole duplication were observed in cell lines derived from mammary tissue, but not in those derived from other tissues. Two BRCA1 variants, R133H and E143K, and a RACK1 variant, K280E, associated with cancer, which weakened the BRCA1-RACK1 interaction, interfered with the centrosomal localization of BRCA1 and reduced centrosome amplification induced by overexpression of RACK1. These results suggest that RACK1 regulates centriole duplication by controlling the centrosomal localization of BRCA1 in mammary tissue-derived cells and that this is dependent on the BRCA1-RACK1 interaction.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30617304     DOI: 10.1038/s41388-018-0647-8

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  1 in total

1.  Identification of a gamma-tubulin-binding domain in BRCA1.

Authors:  L C Hsu; T P Doan; R L White
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

  1 in total
  12 in total

1.  Obg-Like ATPase 1 Enhances Chemoresistance of Breast Cancer via Activation of TGF-β/Smad Axis Cascades.

Authors:  Jianzhou Liu; Xiaoyu Miao; Bowen Xiao; Jing Huang; Xufeng Tao; Jiong Zhang; Hua Zhao; Yue Pan; Hongwei Wang; Ge Gao; Gary Guishan Xiao
Journal:  Front Pharmacol       Date:  2020-05-27       Impact factor: 5.810

Review 2.  The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1.

Authors:  Kei Otsuka; Yuki Yoshino; Huicheng Qi; Natsuko Chiba
Journal:  Genes (Basel)       Date:  2020-07-24       Impact factor: 4.096

Review 3.  Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue-specific carcinogenesis.

Authors:  Yuki Yoshino; Zhenzhou Fang; Huicheng Qi; Akihiro Kobayashi; Natsuko Chiba
Journal:  Cancer Sci       Date:  2021-03-16       Impact factor: 6.716

Review 4.  Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.

Authors:  Erica Buoso; Mirco Masi; Marco Racchi; Emanuela Corsini
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

5.  Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation.

Authors:  Zhengcheng He; Ryan Ghorayeb; Susanna Tan; Ke Chen; Amanda C Lorentzian; Jack Bottyan; Syed Mohammed Musheer Aalam; Miguel Angel Pujana; Philipp F Lange; Nagarajan Kannan; Connie J Eaves; Christopher A Maxwell
Journal:  Nat Commun       Date:  2022-04-22       Impact factor: 17.694

6.  OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis.

Authors:  Yue Liu; Xiang-Xing Kong; Jin-Jie He; Yan-Bo Xu; Jian-Kun Zhang; Lu-Yang Zou; Ke-Feng Ding; Dong Xu
Journal:  BMC Cancer       Date:  2022-04-19       Impact factor: 4.430

Review 7.  Moonlighting at the Poles: Non-Canonical Functions of Centrosomes.

Authors:  Laurence Langlois-Lemay; Damien D'Amours
Journal:  Front Cell Dev Biol       Date:  2022-07-14

8.  Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma.

Authors:  Shanzhou Huang; Chuanzhao Zhang; Chengjun Sun; Yuchen Hou; Yixi Zhang; Nga Lei Tam; Zekang Wang; Jia Yu; Bowen Huang; Hongkai Zhuang; Zixuan Zhou; Zuyi Ma; Zhonghai Sun; Xiaoshun He; Qi Zhou; Baohua Hou; Linwei Wu
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

Review 9.  The Role of the Universally Conserved ATPase YchF/Ola1 in Translation Regulation during Cellular Stress.

Authors:  Victoria Landwehr; Martin Milanov; Jiang Hong; Hans-Georg Koch
Journal:  Microorganisms       Date:  2021-12-23

Review 10.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.